Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Gonadotropin-releasing hormone analog repairs reduced endometrial cell apoptosis in endometriosis in vitro

Article Abstract:

Drugs that mimic gonadotropin-releasing hormone may work by helping cells to undergo natural cell death. These drugs are used to treat endometriosis, a condition caused by the presence of uterine tissue outside the uterus. This abnormal uterine tissue does not undergo cell death as it normally should.

Author: Imai, Atsushi, Takagi, Atsushi, Tamaya, Teruhiko
Publisher: Elsevier B.V.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 2000
Cell death

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Gi protein activation of gonadotropin-releasing hormone-mediated protein dephosphorylation in human endometrial carcinoma

Article Abstract:

Gonadotropin-releasing hormone (GnRH) in cancerous uterine tumors may work with guanosine triphosphate-binding protein (G-protein) to promote malignant cell reproduction. Researchers analyzed cancerous tumors from the inner lining of the uterus for the presence of GnRH and its actions. G-sub-i protein was found to promote the ability of GnRH to interrupt normal protein synthesis and cell reproduction. Such an interruption may allow malignant growth to occur. Pertussis toxin inhibited GnRH interruption of normal protein synthesis. GnRH may follow a different signaling pathway in uterine tumors than it does in the anterior pituitary.

Author: Imai, Atsushi, Takagi, Atsushi, Tamaya, Teruhiko, Horibe, Shinji
Publisher: Elsevier B.V.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 1997
Causes of, Endometrial cancer

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


The failed suppression of serum estradiol level by gonadotropin-releasing hormone agonist in a case of pelvic endometriosis

Article Abstract:

A case is reported of a 42-year-old woman who did not respond to several drugs called gonadotropin-releasing hormone agonists. These drugs are used to suppress the production of estrogen because estrogen can stimulate some tissues, including the endometrium. Thus, these drugs are used to treat endometriosis, which is an abnormal growth of the endometrium. Despite treatment with several different gonadotropin-releasing hormone agonists, her estrogen levels remained normal.

Author: Tamaya, Teruhiko, Misao, Ryou, Nakanishi, Yoshihito
Publisher: Elsevier B.V.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 1998
Estradiol

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Physiological aspects, Drug therapy, Gonadotropin releasing hormone, Gonadorelin, Endometriosis
Similar abstracts:
  • Abstracts: The Preterm Prediction Study: effect of gestational age and cause of preterm birth on subsequent obstetric outcome
  • Abstracts: Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps
  • Abstracts: A comparison of heat-induced hyperactivation in patients' sperm after colloid or pentoxifylline wash methods. Type 5 phosphodiesterase regulation of human sperm motility
  • Abstracts: Deaths Due to Medical Errors Are Exaggerated in Institute of Medicine Report. Institute of Medicine Medical Error Figures Are Not Exaggerated
  • Abstracts: A prospective study of walking as compared with vigorous exercise in the prevention of coronary heart disease in women
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.